Cohance, Suven merger get approval from NSE and BSE
The newly formed company will operate three main verticals: Pharma CDMO, Agrochemicals CDMO, and API manufacturing
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bombay Stock Exchange
Borosil Scientific announces listing on exchange upon strategic demerger from Borosil
The listing follows the strategic demerger of the scientific business from Borosil, completed in December’ 2023 Borosil…
Piramal Pharma lists on BSE and NSE
Piramal Pharma includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organisation (CDMO);…
Avon Lifesciences’ drugs seized, company denies any wrongdoing
Assures cooperating with FDA, investigation agencies in drug seizure case
SPARC’s Rs 250-crore rights issue to open on March 28
The proceeds of the issue will be utilised for meeting costs related to pharma research and development
Torrent Pharma board approves Zyg Pharma’s amalgamation
It will result in concentrated management focus and synergies of operations and facilitating inter transfer of resources and…
Orchid Chemicals & Pharmaceuticals Q1 net loss at Rs 47.56 cr
Posts a net loss of Rs 60.14 crore for the corresponding period of the previous fiscal Drug firm Orchid Chemicals &…
Glenmark issues over one crore shares to Aranda, raises Rs 945 crore
RBI permits FIIs to buy up to 49 per cent stake in Glenmark Glenmark Pharmaceuticals has raised Rs 945 crore by issuing over one…
Sun Pharma gets RBI nod for transfer of Ranbaxy overseas investments
Sun Pharmaceutical Industries has received RBI nod for transfer of overseas investments of Ranbaxy to it and issue its shares to…